Attached files

file filename
EX-99.1 - PRESS RELEASE - Chineseinvestors.com, Inc.chinese_8k-ex9901.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________________

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported):

May 1, 2017

____________________________

 

ChineseInvestors.com, Inc.

(Exact name of registrant as specified in its charter)

____________________________

 

 

Indiana 000-54207 35-2089868
(State of Organization) (Commission File Number) (I.R.S. Employer Identification Number)
     
227 W. Valley Blvd. #208A, San Gabriel, CA   91776
(Address of principal executive offices)   (Zip Code)

 

(800) 808-8760

(Registrant’s telephone number, including area code)

 

Check appropriate box below if the Form 8-K filing is intended to simultaneously satisfying the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company     ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

   

 

 

Item 8.01 Other Events

 

ChineseInvestors.com,, Inc. has issued a new press release regarding the new chief executive officer for XiBiDi Biotechnology Co., Ltd, its wholly owned Chinese subsidiary, Summer Yun.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits.

 

99.1Copy of press release that the Company issued on May 1, 2017 regarding the new chief executive officer for XiBiDi Biotechnology Co., Ltd, its wholly owned Chinese subsidiary, Summer Yun.

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: May 1, 2017

 

ChineseInvestors.com, Inc.

 

By: /s/Wei Wang                               

Name: Wei Wang

Title: Chief Executive Officer

 

 

 

 

 

 

 

 

 

 

 

 2